Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-05-20 Option Award | 2022-05-24 5:12 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | Sharp John P Chief Financial Officer | 6,026 | $0.6813 | 65,767 (Direct) | View |
| 2022-02-24 Option Award | 2022-02-28 7:30 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | Sharp John P Chief Financial Officer | 140,250 | $0 | 140,250 (Direct) | View |
| 2021-11-19 Option Award | 2021-11-23 6:53 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | Sharp John P Chief Financial Officer | 2,017 | $2.01 | 59,741 (Direct) | View |
| 2021-11-03 Exercise | 2021-11-03 7:30 pm | 2020-04-11 2026-05-12 | PhaseBio Pharmaceuticals Inc | PHAS | Sharp John P Chief Financial Officer | 7,500 | $1.68 | 148,306 (Direct) | View |
| 2021-08-03 Exercise(A) | 2021-09-03 4:41 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | Sharp John P Chief Financial Officer | 7,500 | $1.68 | 148,306 (Direct) | View |
| 2021-08-03 Exercise(A) | 2021-09-03 4:41 pm | 2020-04-11 2026-05-12 | PhaseBio Pharmaceuticals Inc | PHAS | Sharp John P Chief Financial Officer | 7,500 | $0 | 148,306 (Direct) | View |
| 2021-08-03 Option Award | 2021-08-04 6:58 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | Sharp John P Chief Financial Officer | 7,500 | $1.68 | 50,224 (Direct) | View |
| 2021-05-20 Option Award | 2021-05-24 6:11 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | Sharp John P Chief Financial Officer | 1,419 | $2.8 | 42,724 (Direct) | View |
| 2021-02-05 Option Award | 2021-02-09 4:48 pm | N/A 2031-02-05 | PhaseBio Pharmaceuticals Inc | PHAS | Sharp John P Chief Financial Officer | 76,500 | $0 | 76,500 (Direct) | View |
| 2020-11-20 Option Award | 2020-11-23 6:43 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | Sharp John P Chief Financial Officer | 1,305 | $3 | 41,305 (Direct) | View |
| 2020-08-14 Exercise | 2020-08-17 8:15 pm | N/A 2026-05-12 | PhaseBio Pharmaceuticals Inc | PHAS | Sharp John P Chief Financial Officer | 5,000 | $0 | 145,582 (Direct) | View |
| 2020-08-14 Exercise | 2020-08-17 8:15 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | Sharp John P Chief Financial Officer | 5,000 | $1.69 | 145,582 (Direct) | View |
| 2020-02-12 Option Award | 2020-02-14 6:49 pm | N/A 2030-02-12 | PhaseBio Pharmaceuticals Inc | PHAS | Sharp John P Chief Financial Officer | 100,000 | $0 | 100,000 (Direct) | View |